Emerging adult age status predicts poor buprenorphine treatment retention

Schuman-Olivier, Zev; Weiss, Roger D.; Hoeppner, Bettina B.; Borodovsky, Jacob; Albanese, Mark J.

doi:10.1016/j.jsat.2014.04.006

Cited by 127Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPersonality Disorders and Psychopathology

Emerging adult age status predicts poor buprenorphine treatment retention

Open access

Schuman-Olivier, Zev, Weiss, Roger D., Hoeppner, Bettina B., Borodovsky, Jacob, Albanese, Mark J.·2014·Journal of Substance Abuse Treatment

DOI 10.1016/j.jsat.2014.04.006PMC PMC4180514

Open this paper in CoChat — free account

Abstract

Emerging adults (18-25 years old) are often poorly retained in substance use disorder treatment. Office-based buprenorphine often enhances treatment retention among people with opioid dependence. In this study, we examined the records of a collaborative care buprenorphine treatment program to compare the treatment retention rates of emerging adults versus older adults. Subjects were 294 adults, 71 (24%) aged 18-25, followed in treatment with buprenorphine, nurse care management, and an intensive outpatient program followed by weekly psychosocial treatment. Compared to older adults, emerging adults remained in treatment at a significantly lower rate at 3 months (56% versus 78%) and 12 months (17% versus 45%), and were significantly more likely to test positive for illicit opioids, relapse, or drop out of treatment. Further research into factors associated with buprenorphine treatment retention among emerging adults is needed to improve treatment and long-term outcomes in this group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2014.04.006

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Ongoing opioid use, comorbid cocaine use, psychosocial stress, and psychiatric comorbidity such as anxiety or PTSD predict poorer retention in buprenorphine/naloxone treatment.
“Ongoing opioid use, comorbid cocaine use, psychosocial stress and psychiatric comorbidity (e.g., anxiety, PTSD) predict poor retention rates (Ecker & Hundt, 2018; Gerra et al., 2006; Schuman-Olivier et al., 2014; Sullivan et al., 2010).”
From Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study (2021) · cites this paper as Schuman-Olivier et al., 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Emerging adulthood: A theory of development from the late teens through the twenties.
Arnett, J. J. (2000) · American Psychologist · doi:10.1037/0003-066x.55.5.469 · Cited by 16,843 · see citing works
Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930 · see citing works
Dynamic mapping of human cortical development during childhood through early adulthood
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402680101 · Cited by 5,604 · cited 2× · see citing works
“…of cortical pruning and myelination needed for the development of executive function are underway during this time period (Giedd et al., 1999; Gogtay et al., 2004; Lebel & Beaulieu, 2011; Marsh, Gerber, & Peterson, 2008) and can be disrupted by substance abuse (Jacobus et al., 2009; Medina,…”
Background
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552 · see citing works
The Epidemiologic Transition: A Theory of the Epidemiology of Population Change
Omran, A. R. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00398.x · Cited by 3,891 · see citing works
Why People Use Health Services
Rosenstock, I. M. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00425.x · Cited by 2,329 · see citing works
Why People Use Health Services
Rosenstock, I. M. (1966) · The Milbank Memorial Fund Quarterly · doi:10.2307/3348967 · Cited by 2,305 · see citing works
Monitoring the Future national survey results on drug use, 1975-2017: Volume I, secondary school students
Miech, R., Johnston, L. A., O'Malley, P., Bachman, J., Schulenberg, J., & Patrick, M. E. (2005) · doi:10.3998/2027.42/146530 · Cited by 1,771 · see citing works
Longitudinal Development of Human Brain Wiring Continues from Childhood into Adulthood
Lebel, C., & Beaulieu, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5302-10.2011 · Cited by 1,193 · see citing works
The Developmental Context of Substance use in Emerging Adulthood
Arnett, J. J. (2005) · Journal of Drug Issues · doi:10.1177/002204260503500202 · Cited by 1,033 · see citing works
Models of Community Care for Severe Mental Illness: A Review of Research on Case Management
Mueser, K. T., Bond, G. R., Drake, R. E., & Resnick, S. G. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033314 · Cited by 859 · see citing works
Review of risk and protective factors of substance use and problem use in emerging adulthood
Stone, A. L., Becker, L. G., Huber, A. M., & Catalano, R. F. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.02.014 · Cited by 843 · see citing works
A Flood of Opioids, a Rising Tide of Deaths
Okie, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011512 · Cited by 832 · see citing works
Substance Abuse and Mental Health Services Administration
Fisher, G. L., & Roget, N. A. (2009) · Sage eBooks · doi:10.4135/9781412964500.n301 · Cited by 718 · see citing works
Neurobiology of the Adolescent Brain and Behavior: Implications for Substance Use Disorders
Casey, B. J., & Jones, R. M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.08.017 · Cited by 692 · see citing works
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577 · cited 1× · see citing works
“Maintenance treatment with buprenorphine has been demonstrated to be more effective for opioid dependence than detoxification or placebo (Fudala et al., 2003; Johnson, Jaffe, & Fudala, 1992; Weiss et al., 2011).”
Background
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA · doi:10.1001/jama.1992.03480200058024 · Cited by 567 · see citing works
Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540 · see citing works
Self-citation
Drug poisoning deaths in the United States, 1980-2008.
Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Miniño, A. (2011) · PubMed · Cited by 399 · see citing works
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial
Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA · doi:10.1001/jama.2008.574 · Cited by 361 · see citing works
Effect of Abuse-Deterrent Formulation of OxyContin
Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1204141 · Cited by 337 · see citing works
Drug abuse treatment retention and process effects on follow-up outcomes
Simpson, D. D., Joe, G. W., & Rowan‐Szal, G. A. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00099-9 · Cited by 319 · see citing works
Does retention matter? Treatment duration and improvement in drug use
Zhang, Z., Friedmann, P. D., & Gerstein, D. R. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00354.x · Cited by 314 · see citing works
Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study
Clausen, T., Anchersen, K., & Waal, H. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.003 · Cited by 287 · see citing works
Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry
Lisdahl, K. M., Schweinsburg, A. D., Cohen‐Zion, M., Nagel, B. J., & Tapert, S. F. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.10.010 · Cited by 280 · see citing works
Neuroimaging Studies of Normal Brain Development and Their Relevance for Understanding Childhood Neuropsychiatric Disorders
Marsh, R., Gerber, A. J., & Peterson, B. S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318185e703 · Cited by 267 · see citing works
Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine: Five-Year Experience
Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., & Samet, J. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.541 · Cited by 267 · see citing works
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237 · see citing works
Impact of adolescent alcohol and drug use on neuropsychological functioning in young adulthood: 10-year outcomes
Hanson, K. L., Medina, K. L., Padula, C. B., Tapert, S. F., & Brown, S. A. (2011) · Journal of Child & Adolescent Substance Abuse · doi:10.1080/1067828x.2011.555272 · Cited by 235 · see citing works
A Theory of Development From the Late Teens Through the Twenties
Arnett, J. J. (2000) · Cited by 227 · see citing works
Entering treatment for alcohol abuse: a stress and coping model.
Finney, J., & Moos, R. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.90912237.x · Cited by 208 · see citing works
Emerging adulthood(s): The cultural psychology of a new life stage.
Arnett, J. J. (2011) · Cited by 208 · see citing works
Mobile health 2012
Duggan, M., & Fox, S. (2012) · Issue Lab (Candid) · Cited by 199 · see citing works
White matter integrity in adolescents with histories of marijuana use and binge drinking
Jacobus, J., McQueeny, T. M., Bava, S., Schweinsburg, B. C., Frank, L. R., Yang, T. T., & Tapert, S. F. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.07.006 · Cited by 186 · see citing works
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
Soyka, M., Zingg, C., Koller, G., & Küfner, H. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570700836x · Cited by 184 · see citing works
The Case for Chronic Disease Management for Addiction
Saitz, R., Larson, M. J., LaBelle, C. T., Richardson, J. M., & Samet, J. H. (2008) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318166af74 · Cited by 165 · see citing works
Long‐Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 Years
Fiellin, D. A., Moore, B. A., Sullivan, L. E., Becker, W. C., Pantalon, M. V., Chawarski, M. C., Barry, D. T., O’Connor, P. G., & Schottenfeld, R. S. (2008) · American Journal on Addictions · doi:10.1080/10550490701860971 · Cited by 162 · see citing works
Effect of Buprenorphine Dose on Treatment Outcome
Fareed, A., Vayalapalli, S., Casarella, J., & Drexler, K. P. G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.642758 · Cited by 157 · see citing works
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
Pani, P., Maremmani, I., Pirastu, R., Tagliamonte, A., & Gessa, G. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00140-4 · Cited by 149 · see citing works
Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year
Soeffing, J. M., Martin, L. D., Fingerhood, M., Jasinski, D. R., & Rastegar, D. A. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.05.003 · Cited by 144 · see citing works
Pretreatment and during treatment risk factors for dropout among patients with substance use disorders
McKellar, J., Kelly, J., Harris, A., & Moos, R. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.05.024 · Cited by 125 · see citing works
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
Dreifuss, J. A., Griffin, M. L., Frost, K. H., Fitzmaurice, G. M., Potter, J. S., Fiellin, D. A., Selzer, J. A., Hatch‐Maillette, M. A., Sonne, S. C., & Weiss, R. D. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.010 · Cited by 122 · see citing works
Self-citation
Entering treatment for alcohol abuse: a stress and coping model
Finney, J. W., & Moos, R. H. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01092.x · Cited by 120 · see citing works
Prevalence and impact of substance use among emerging adults with serious mental health conditions.
Sheidow, A. J., McCart, M. R., Zajac, K., & Davis, M. (2012) · Psychiatric Rehabilitation Journal · doi:10.2975/35.3.2012.235.243 · Cited by 118 · see citing works
How Patients Recovering From Alcoholism Use a Smartphone Intervention
Mctavish, F. M., Chih, M., Shah, D. V., & Gustafson, D. H. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.723312 · Cited by 112 · see citing works
Treating Substance Abuse: Partner and Family Approaches
Klostermann, K. C., & O’Farrell, T. J. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.759014 · Cited by 107 · see citing works
Patient histories, retention, and outcome models for younger and older adults in DATOS
Grella, C. E., Hser, Y., Joshi, V., & Anglin, M. D. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00082-4 · Cited by 98 · see citing works
Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers
Schuman‐Olivier, Z., Albanese, M. A., Nelson, S. E., Roland, L., Puopolo, F., Klinker, L., & Shaffer, H. J. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.03.014 · Cited by 94 · see citing works
Self-citation
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)
Darke, S. G., Ross, J. E., Teesson, M., Ali, R. L., Cooke, R., Ritter, A., & Lynskey, M. T. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.01.006 · Cited by 88 · see citing works
Social recovery model: an 8-year investigation of adolescent 12-step group involvement following inpatient treatment.
Kelly, J., Brown, S. A., Abrantes, A., Kahler, C., & Myers, M. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00712.x · Cited by 88 · see citing works
Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes
Schuman‐Olivier, Z., Hoeppner, B. B., Weiss, R. D., Borodovsky, J. T., Shaffer, H. J., & Albanese, M. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.006 · Cited by 84 · see citing works
Self-citation
Predictors of Dropout from Psychosocial Treatment in Opioid‐Dependent Outpatients
McHugh, R. K., Murray, H. W., Hearon, B. A., Pratt, E. M., Pollack, M. H., Safren, S. A., & Otto, M. W. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.00317.x · Cited by 83 · see citing works
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Marsch, L. A., Stephens, M. A. C., Mudric, T., Strain, E. C., Bigelow, G. E., & Johnson, R. E. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.4.293 · Cited by 75 · see citing works
The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office‐Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence
Sullivan, L. E., Moore, B. A., O’Connor, P. G., Barry, D. T., Chawarski, M. C., Schottenfeld, R. S., & Fiellin, D. A. (2009) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00003.x · Cited by 67 · see citing works
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
Warden, D., Subramaniam, G., Carmody, T. J., WOODY, G. E., Minhajuddin, A., Poole, S. A., Potter, J. S., Fishman, M. J., Bogenschutz, M. P., Patkar, A. A., et al. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.011 · Cited by 66 · see citing works
Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth
Subramaniam, G., Warden, D., Minhajuddin, A., Fishman, M. J., Stitzer, M. L., Adinoff, B. H., Trivedi, M. H., Weiss, R. D., Potter, J. S., Poole, S. A., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.07.010 · Cited by 54 · see citing works
Self-citation
Frequency of Prescription Pain Reliever Nonmedical Use: 2002-2003 and 2009-2010
Jones, C. M. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.2533 · Cited by 53 · see citing works
Adolescent Community Reinforcement Approach outcomes differ among emerging adults and adolescents
Smith, D. C., Godley, S. H., Godley, M. D., & Dennis, M. L. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.06.003 · Cited by 51 · see citing works
Bridging Cultural and Developmental Approaches to Psychology
Jensen, L. A. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195383430.001.0001 · Cited by 48 · see citing works
Office-Based Maintenance Treatment of Opioid Dependence
Gunderson, E. W., & Fiellin, D. A. (2008) · CNS Drugs · doi:10.2165/00023210-200822020-00002 · Cited by 47 · see citing works
Smartphone Ownership - 2013 Update
Smith, A. (2013) · Issue Lab (Candid) · Cited by 45 · see citing works
The added risk of opioid problem use among treatment‐seeking youth with marijuana and/or alcohol problem use
Subramaniam, G., Ives, M. L., Stitzer, M. L., & Dennis, M. L. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02829.x · Cited by 43 · see citing works
Reasons for Quitting Among Emerging Adults and Adolescents in Substance-Use-Disorder Treatment
Smith, D. C., Cleeland, L. R., & Dennis, M. L. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.400 · Cited by 43 · see citing works
“Ready, willing, and (not) able” to change: Young adults’ response to residential treatment
Kelly, J. F., Urbanoski, K. A., Hoeppner, B. B., & Slaymaker, V. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.003 · Cited by 42 · see citing works
Self-citation
Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile
Öhlin, L., Hesse, M., Fridell, M., & Tätting, P. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-81 · Cited by 32 · see citing works
Transition Age Youth in Publicly Funded Systems: Identifying High-Risk Youth for Policy Planning and Improved Service Delivery
Heflinger, C. A., & Hoffman, C. (2006) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-006-9042-2 · Cited by 24 · see citing works
Community opioid treatment perspectives on contingency management: Perceived feasibility, effectiveness, and transportability of social and financial incentives
Hartzler, B. J., & Rabun, C. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.01.014 · Cited by 19 · see citing works
Contingency Management Is Efficacious in Opioid-Dependent Outpatients Not Maintained on Agonist Pharmacotherapy
Petry, N., & Carroll, K. (2013) · Psychology of Addictive Behaviors · doi:10.1037/a0032175 · Cited by 18 · see citing works
Examining Drug Treatment Entry Patterns Among Young Injection Drug Users
Shin, S. H., Lundgren, L. M., & Chassler, D. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990601174774 · Cited by 17 · see citing works
The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone—experience from a medium-sized Finnish city
Tervonen, H. E., Pentikäinen, H., & Tacke, U. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.01.003 · Cited by 14 · see citing works
Willingness and Appropriateness of Peers Participating in Emerging Adults’ Substance Misuse Treatment
Smith, D., Cleeland, L., Middleton, A. V., & Godley, M. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.01.008 · Cited by 14 · see citing works
Impact of Lifetime Alcohol Quit Attempts and Medicated Detoxifications on Time to Relapse During an Index Alcohol Detoxification
Wright, T. M., Myrick, H., Malcolm, R. J., Randall, P. A., Boyle, E. A., Henderson, S., & Anton, R. F. (2007) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318044ce4f · Cited by 6 · see citing works
A simple method for converting an odds ratio to effect size for use in meta-analysis
Chinn, S. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001130)19:22

Flagged first, then by citations

2 of the 75 references couldn’t be matched to a known paper.

Sorted by citations

Medication-Assisted Treatment of Adolescents With Opioid Use Disorders
Ryan, S. A., Gonzalez, P. K., Patrick, S. W., Quigley, J. M., Siqueira, L. M., & Walker, L. R. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1893 · Cited by 224 · see citing works
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
Hadland, S. E., Bagley, S. M., Rodean, J., Silverstein, M., Levy, S., Larochelle, M. R., Samet, J. H., & Zima, B. T. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.2143 · Cited by 220 · see citing works
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Krawczyk, N., Williams, A. R., Saloner, B. K., & Cerdá, M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108329 · Cited by 145 · see citing works
Substance Use Among College Students
Welsh, J. W., Shentu, Y., & Sarvey, D. B. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20180037 · Cited by 156 · see citing works
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature
Lyons, R. M., Yule, A. M., Schiff, D. M., Bagley, S. M., & Wilens, T. E. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0013 · Cited by 116 · see citing works
Opioid Use Disorders
Sharma, B., Bruner, A. B., Barnett, G., & Fishman, M. J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.03.002 · Cited by 112 · see citing works
A randomized controlled trial of buprenorphine taper duration among opioid‐dependent adolescents and young adults
Marsch, L. A., Moore, S. K., Borodovsky, J. T., Solhkhah, R., Badger, G. J., Semino, S. J., Jarrett, K., Condon, K. A. D., Rossettie, K., Vincent, P., et al. (2016) · Addiction · doi:10.1111/add.13363 · Cited by 97 · see citing works
Self-citation
Predictors of early dropout in outpatient buprenorphine/naloxone treatment
Marcovitz, D. E., McHugh, R. K., Volpe, J., Votaw, V. R., & Connery, H. S. (2016) · American Journal on Addictions · doi:10.1111/ajad.12414 · Cited by 86 · see citing works
Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research
Moningka, H., Lichenstein, S. D., Worhunsky, P. D., DeVito, E. E., Scheinost, D., & Yip, S. W. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0232-4 · Cited by 83 · see citing works
Youth and the Opioid Epidemic
Levy, S. (2019) · PEDIATRICS · doi:10.1542/peds.2018-2752 · Cited by 78 · see citing works
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
Frost, M. C., Lampert, H., Tsui, J. I., Iles-Shih, M., & Williams, E. C. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00266-2 · Cited by 82 · see citing works
Outcomes for Physicians With Opioid Dependence Treated Without Agonist Pharmacotherapy in Physician Health Programs
Merlo, L. J., Campbell, M. D., Skipper, G. E., Shea, C. L., & DuPont, R. L. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.02.004 · Cited by 77 · see citing works
Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review
Borodovsky, J. T., Levy, S., Fishman, M. J., & Marsch, L. A. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000388 · Cited by 70 · see citing works
Self-citation
Evidence-Based Treatment of Young Adults With Substance Use Disorders
Hadland, S. E., Yule, A. M., Levy, S., Hallett, E., Silverstein, M., & Bagley, S. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-023523d · Cited by 69 · see citing works
Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
Bhatraju, E. P., Grossman, E., Tofighi, B., McNeely, J., DiRocco, D., Flannery, M., Garment, A. R., Goldfeld, K. S., Gourevitch, M. N., & Lee, J. D. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-017-0072-2 · Cited by 64 · see citing works
Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities
Marshall, B. D. L., Green, T. C., Yedinak, J. L., & Hadland, S. E. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.01.022 · Cited by 64 · see citing works
Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults
Viera, A., Bromberg, D. J., Whittaker, S., Refsland, B. M., Stanojlović, M., Nyhan, K., & Altice, F. L. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa001 · Cited by 62 · see citing works
Group-based treatment of opioid use disorder with buprenorphine: A systematic review
Sokol, R., LaVertu, A. E., Morrill, D., Albanese, C., & Schuman-Olivier, Z. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.11.003 · Cited by 50 · see citing works
Self-citation
"The Age of Feeling in-Between": Addressing Challenges in the Treatment of Emerging Adults With Substance Use Disorders
Bergman, B. G., Kelly, J. F., Nargiso, J. E., & McKowen, J. W. (2016) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2015.09.008 · Cited by 50 · see citing works
Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions
Chang, D. C., Klimas, J., Wood, E., & Fairbairn, N. S. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1399403 · Cited by 48 · see citing works
Grit in patients with substance use disorders
Griffin, M. L., McDermott, K. A., McHugh, R. K., Fitzmaurice, G. M., & Weiss, R. D. (2016) · American Journal on Addictions · doi:10.1111/ajad.12460 · Cited by 47 · see citing works
Self-citation
Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder
Fishman, M. J., Wenzel, K. R., Scodes, J. M., Pavlicová, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.07.038 · Cited by 46 · see citing works
MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
Schuman-Olivier, Z., Borodovsky, J. T., Steinkamp, J., Munir, Q., Butler, K., Greene, M. A., Goldblatt, J., Xie, H. Y., & Marsch, L. A. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0122-4 · Cited by 44 · see citing works
Self-citation
Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder
Schuman‐Olivier, Z., Greene, M. C., Bergman, B. G., & Kelly, J. F. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.09.009 · Cited by 42 · see citing works
Self-citation
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults
Welsh, J. W., Dennis, M. L., Funk, R. R., Mataczynski, M. J., & Godley, M. D. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108584 · Cited by 39 · see citing works
The effects of continuing care on emerging adult outcomes following residential addiction treatment
Bergman, B. G., Hoeppner, B. B., Nelson, L. M., Slaymaker, V. J., & Kelly, J. F. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.017 · Cited by 34 · see citing works
Self-citation
Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review
Dalton, K., Bishop, L., & Darcy, S. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107005 · Cited by 35 · see citing works
A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders
Dayal, P., & Balhara, Y. P. S. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.06.004 · Cited by 34 · see citing works
Extended-release naltrexone for youth with opioid use disorder
Mitchell, S. G., Monico, L. B., Gryczynski, J., Fishman, M. J., O’Grady, K. E., & Schwartz, R. P. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108407 · Cited by 33 · see citing works
Ambivalence and stigma beliefs about medication treatment among young adults with opioid use disorder: A qualitative exploration of young adults’ perspectives
Bagley, S. M., Schoenberger, S. F., dellaBitta, V., Lunze, K., Barron, K., Hadland, S. E., & Park, T. W. (2023) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.08.026 · Cited by 33 · see citing works
Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder
Golan, O. K., Totaram, R., Perry, E. W., Fortson, K., Rivera-Atilano, R., Entress, R. M., Golan, M., Andraka‐Christou, B., Whitaker, D. J., & Pigott, T. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109445 · Cited by 34 · see citing works
Opioid Use Disorder Treatment Facilities With Programs for Special Populations
Hadland, S. E., Jent, V. A., Alinsky, R. H., Marshall, B. D. L., Mauro, P. M., & Cerdá, M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.03.022 · Cited by 32 · see citing works
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York
Neighbors, C. J., Choi, S., Healy, S., Yerneni, R., Sun, T., & Shapoval, L. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0215-4 · Cited by 30 · see citing works
Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment
Carlsen, S.-E. L., Lunde, L.-H., & Torsheim, T. (2020) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s221618 · Cited by 30 · see citing works
A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder
Azar, P., Wong, J. S. H., Jassemi, S., Moore, E. M., Vo, D. X., Nikoo, M., & Young, S. (2020) · American Journal on Addictions · doi:10.1111/ajad.13050 · Cited by 30 · see citing works
Emerging Adults in Inpatient Substance Use Treatment: A Prospective Cohort Study of Patient Characteristics and Treatment Outcomes
Andersson, H. W., Lauvsnes, A. D. F., & Nordfjærn, T. (2020) · European Addiction Research · doi:10.1159/000512156 · Cited by 30 · see citing works
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
Laffont, C. M., Ngaimisi, E., Gopalakrishnan, M., Ivaturi, V. D., Young, M. A., Greenwald, M. K., & Heidbreder, C. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1052113 · Cited by 30 · see citing works
Relapse Prevention Medications in Community Treatment for Young Adults with Opioid Addiction
Vo, H. T., Robbins, E., Westwood, M., Lezama, D., & Fishman, M. J. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1143435 · Cited by 29 · see citing works
Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine
Hui, D. S. C., Weinstein, Z., Cheng, D. M., Quinn, E. K., Kim, H. W., LaBelle, C. T., & Samet, J. H. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.05.010 · Cited by 29 · see citing works
Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment
Schuman‐Olivier, Z., Goodman, H., Rosansky, J. A., Fredericksen, A. K., Barria, J., Parry, G. J., Sokol, R. G., Gardiner, P. M., Cook, B. L., & Weiss, R. D. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54950 · Cited by 24 · see citing works
Self-citation
Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose: A Quality Improvement Project
Nelson, S. D., McCoy, A. B., Rector, H., Teare, A. J., Barrett, T. W., Sigworth, E. A., Chen, Q., Edwards, D. A., Marcovitz, D. E., & Wright, A. T. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005976 · Cited by 23 · see citing works
Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment with Buprenorphine: A Pilot Study
Suzuki, J., Zinser, J., Klaiber, B., Hannon, M., Grassi, H., Spinosa, M., Ramirez, A., Issa, M., & Feman, S. P. C. (2015) · Substance Abuse · doi:10.1080/08897077.2014.998400 · Cited by 22 · see citing works
Home-based delivery of XR-NTX in youth with opioid addiction
Vo, H. T., Burgower, R., Rozenberg, I., & Fishman, M. J. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.08.007 · Cited by 21 · see citing works
The Promise and Peril of Emerging Adulthood: Introduction to the Special Issue
Henin, A., & Berman, N. C. (2016) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2016.05.005 · Cited by 21 · see citing works
An Exploration of Young Adults With Opioid Use Disorder and How Their Perceptions of Family Members’ Beliefs Affects Medication Treatment
Bagley, S. M., Schoenberger, S. F., dellaBitta, V., Lunze, K., Barron, K., Hadland, S. E., & Park, T. W. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001001 · Cited by 21 · see citing works
Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders
O’Brien, P. L., Henke, R. M., Schaefer, M. B., Lin, J. R., & Creedon, T. B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108555 · Cited by 19 · see citing works
Virtual Care in an Outpatient Subspecialty Substance Use Disorder Treatment Program
Levy, S., Deister, D., Fantegrossi, J., Green, L., Lunstead, J., Martinez, T., Riccardelli, W., Schizer, M. A., Schram, J., Schram, P., et al. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000871 · Cited by 19 · see citing works
Challenges and Gaps in Understanding Substance Use Problems in Transitional Age Youth
Bukstein, O. G. (2017) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.12.005 · Cited by 19 · see citing works
A systematic review of interventions to enhance initiation of and adherence to treatment for alcohol use disorders
Biswal, B., Bora, S., Anand, R., Bhatia, U., Fernandes, A., Joshi, M., & Nadkarni, A. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112429 · Cited by 19 · see citing works
Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention
Wenzel, K. R., Selby, V., Wildberger, J., Lavorato, L., Thomas, J. L., & Fishman, M. J. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108306 · Cited by 18 · see citing works
Integrating peer support services into primary care-based OUD treatment: Lessons from the Penn integrated model
Harris, R. A., Campbell, K., Calderbank, T., Dooley, P., Aspero, H., Maginnis, J., O'Donnell, N., Coviello, D., French, R., Bao, Y., et al. (2022) · Healthcare · doi:10.1016/j.hjdsi.2022.100641 · Cited by 17 · see citing works
HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
Page, K. A., Evans, J. L., Hahn, J. A., Vickerman, P. T., SHIBOSKI, S. C., & Morris, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226166 · Cited by 17 · see citing works
Integrating substance use care into primary care for adolescents and young adults: Lessons learned
Bagley, S. M., Hadland, S. E., Schoenberger, S. F., Gai, M. J., Topp, D., Hallett, E., Ashe, E. M., Samet, J. H., & Walley, A. Y. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108376 · Cited by 17 · see citing works
Treatment Trajectories During and After a Medication Trial for Opioid Use Disorder: Moving from Research as Usual to Treatment as Usual
Fishman, M. J., Vo, H. T., Burgower, R., Ruggiero, M. S., Rotrosen, J., Lee, J., & Nunes, E. V. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000592 · Cited by 17 · see citing works
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities
Fishman, M. J., Wenzel, K. R., Gauthier, P. R., Borodovsky, J. T., Murray, O., Subramaniam, G., Levy, S., Fredyma, E., McLeman, B. M., & Marsch, L. A. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209352 · Cited by 16 · see citing works
Self-citation
A Review of Behavioral Therapies in Adolescents with Opioid Use Disorder
Welsh, J. W., Mataczynski, M. J., Nguyen, M. D., & McHugh, R. K. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000272 · Cited by 16 · see citing works
One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine/Naloxone for the First Time in a Substance Treatment Unit
Mutlu, C., Demirci, A. Ç., Yalçın, Ö., Kılıçoğlu, A. G., Topal, M., & Karaçetin, G. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.04.002 · Cited by 16 · see citing works
Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada
Pilarinos, A., Kwa, Y., Joe, R. S., Dong, H., Grant, C. C., Fast, D., Buxton, J. A., & DeBeck, K. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221136468 · Cited by 15 · see citing works
Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults
Choi, S., Biello, K. B., Bazzi, A. R., & Drainoni, M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.030 · Cited by 15 · see citing works
Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders
O’Brien, P. L., Henke, R. M., Schaefer, M. B., Lin, J. R., & Creedon, T. B. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108261 · Cited by 15 · see citing works
Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment
Justesen, K., Hooker, S. A., Sherman, M. D., Lonergan, M. E., Nissly, T. J., & Levy, R. J. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.06.200086 · Cited by 14 · see citing works
Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation
Sokol, R., Albanese, M., Chew, A., Early, J., Grossman, E., Roll, D., Sawin, G., Wu, D. J., & Schuman-Olivier, Z. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0176-y · Cited by 14 · see citing works
Self-citation
Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study
Fatkin, T., Moore, S. K., Okst, K., Creedon, T. B., Samawi, F., Fredericksen, A. K., Roll, D., Oxnard, A., Lê Cook, B., & Schuman-Olivier, Z. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108415 · Cited by 14 · see citing works
Self-citation
Interventions to Reduce Opioid Use in Youth At-Risk and in Treatment for Substance Use Disorders: A Scoping Review
Nairn, S. A., Audet, M., Stewart, S. H., Hawke, L. D., Isaacs, J. Y., Henderson, J. L., Haines‐Saah, R., Knight, R., Fast, D., Khan, F., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221089810 · Cited by 14 · see citing works
College Student Preferences for Substance Use Disorder Educational Videos: A Qualitative Study
Andraka-Christou, B., Alex, B., & Lyneé Madeira, J. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1581816 · Cited by 13 · see citing works
A Phone Consultation Call Line to Support SBIRT in Pediatric Primary Care
Levy, S., Fuller, A., Kelly, S., Lunstead, J., Weitzman, E. R., & Straus, J. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.882486 · Cited by 13 · see citing works
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study
Hoffman, K., Peyton, M. L., & Sumner, M. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000301 · Cited by 13 · see citing works
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder
Barbosa‐Leiker, C., Campbell, A. N. C., Pavlicová, M., Scodes, J. M., Burlew, A. K., Hatch‐Maillette, M. A., Mennenga, S. E., Mitchell, S. G., Novo, P., Nunes, E. V., et al. (2020) · American Journal on Addictions · doi:10.1111/ajad.13059 · Cited by 13 · see citing works
Analysis of genetic and clinical factors associated with buprenorphine response
Crist, R. C., Vickers‐Smith, R., Kember, R. L., Rentsch, C. T., Xu, H., Edelman, E. J., Hartwell, E. E., Kampman, K. M., & Kranzler, H. R. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109013 · Cited by 12 · see citing works
Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management
Sidlak, A. M., Dibble, B., Dhaliwal, M., Bottone, P. D., Marino, R. T., Henry, L. L., & Howell, J. M. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111136 · Cited by 12 · see citing works
The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations
Marsch, L. A., Chen, C.-H., Adams, S. R., Asyyed, A. H., Does, M. B., Hassanpour, S., Hichborn, E. G., Jackson-Morris, M., Jacobson, N. C., Jones, H. K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871916 · Cited by 11 · see citing works
Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
Lillie, K., Shaw, J. L., Jansen, K. J., & Garrison, M. M. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000757 · Cited by 13 · see citing works
Evaluating substance use treatment efficacy for younger and older adults
Dingle, T., & Bowen, S. W. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106618 · Cited by 10 · see citing works
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid‐related health problems: a population‐based retrospective cohort study
Paul, L. A., Bayoumi, A. M., Chen, C., Kocovska, E., Smith, B. T., Raboud, J., Gomes, T., Kendall, C., Rosella, L. C., Bitonti‐Bengert, L., et al. (2022) · Addiction · doi:10.1111/add.16096 · Cited by 9 · see citing works
Treatment Retention and Outcomes with the Adolescent Community Reinforcement Approach in Emerging Adults with Opioid Use
Welsh, J. W., Passetti, L. L., Funk, R. R., Smith, J. E., Meyers, R. J., & Godley, M. D. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1613585 · Cited by 9 · see citing works
Psychosocial Approaches in the Treatment of Opioid Use Disorders
Bergman, B. G., Fallah‐Sohy, N., Hoffman, L. A., & Kelly, J. F. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_6 · Cited by 14 · see citing works
Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults
Peck, K. R., Ochalek, T. A., Badger, G. J., & Sigmon, S. C. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107879 · Cited by 9 · see citing works
Multidimensional Family Therapy for Justice-Involved Young Adults with Substance Use Disorders
Liddle, H. A., Dakof, G. A., Rowe, C. L., Mohamed, A. S., Henderson, C. E., Foulkrod, T., Lucas, M., & DiFrancesco, M. (2023) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-023-09852-5 · Cited by 8 · see citing works
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial
Fishman, M. J., Wenzel, K. R., Scodes, J. M., Pavlicová, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. V. (2021) · American Journal on Addictions · doi:10.1111/ajad.13176 · Cited by 8 · see citing works
Testing a Matching Hypothesis for Emerging Adults in Project MATCH: During-Treatment and One-Year Outcomes
Davis, J. P., Bergman, B. G., Smith, D. C., & Kelly, J. F. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.140 · Cited by 8 · see citing works
Medication Treatment for Opioid-Addicted Youth—What Are We Waiting for?
WOODY, G. E., & Fishman, M. J. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.04.002 · Cited by 7 · see citing works
Risk Factors for Treatment Drop-Out: Implications for Adverse Outcomes When Treating Opioid Use Disorder
Iovine, P. A., Drachman, D., & Kirane, H. (2020) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2020.1838859 · Cited by 6 · see citing works
Foundations of addictive problems in adolescents: Developmental and social factors
Preyde, M., Furtado, J., Head, S., & Long, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818626-8.00001-3 · Cited by 6 · see citing works
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults
Welsh, J. W., Krishnan, S. D., & Terranella, A. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01638-0 · Cited by 5 · see citing works
Implementation outcomes from a pilot study of training probation officers to deliver contingency management for emerging adults with substance use disorders
Drazdowski, T. K., Kelton, K., Hibbard, P. F., McCart, M. R., Chapman, J. E., de Martell, S. C., & Sheidow, A. J. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209450 · Cited by 5 · see citing works
Default Mode Network Functional Reorganization During Early Abstinence in Polysubstance-Using Emerging Adults Treated for Opioid Dependence
Copersino, M. L., Price, J. S., Frost, K. H., Vitaliano, G. D., Frederick, B. B., Lukas, S. E., Weiss, R. D., & Janes, A. C. (2016) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15090240 · Cited by 5 · see citing works
Self-citation
Treatment Retention in Opioid Dependent Clients Receiving Medication-Assisted Treatment: Six-Month Rate and Baseline Correlates
Fendrich, M., Becker, J., Ives, M. L., Rodis, E., & Marin, M. C. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1906276 · Cited by 5 · see citing works
Using the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) to Predict Gambling Disorder Among U.S. College Students
Qeadan, F., Egbert, J., Tingey, B., Plum, A., & Pasewark, T. (2024) · Journal of Gambling Studies · doi:10.1007/s10899-024-10283-w · Cited by 5 · see citing works
Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference
Armstrong, C., Ferrante, J. R., Lamichhane, N., Gamard, C., Reavis, Z., Walker, Q. D., Zucker, N., Patkar, A., & Kuhn, C. M. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173485 · Cited by 4 · see citing works
Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults
Aleksanyan, J., Choi, S., Lincourt, P., Burke, C., Ramsey, K. S., Hussain, S., Jordan, A. E., Morris, M., D’Aunno, T. A., Glied, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297567 · Cited by 4 · see citing works
Understanding the needs of postpartum emerging adults with substance use disorders to improve recovery supports
Cioffi, C. C., Lewis, L. F., & Gau, J. M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1521093 · Cited by 3 · see citing works
The role of polysubstance use in the development, maintenance, and treatment of stimulant use disorders
Rough, M. I., & Nader, M. A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100119 · Cited by 3 · see citing works
Higher perceived stress during admission is associated with shorter retention in short-term residential substance use disorder treatment
Ware, O. D., Sacco, P., Cagle, J. G., Frey, J. J., Wagner, F. A., Wimberly, A. S., Gyebi-Foster, B., Diaz, M., Peters, K., & Zemore, S. E. (2023) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2023.100502 · Cited by 4 · see citing works
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural Settings
Flores, J. M., Kan, E., Mooney, L. J., Pham, H., Zhu, Y., Wolitzky-Taylor, K. B., & Hser, Y. (2024) · JAACAP Open · doi:10.1016/j.jaacop.2024.02.001 · Cited by 3 · see citing works
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller, E. A., McGinnis, K. A., Edelman, E. J., Feinberg, T., Gordon, K. S., Kerns, R. D., Marshall, B. D. L., Patterson, J. A., & McRae, M. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04494-w · Cited by 3 · see citing works
Organization of primary care and early MOUD discontinuation
Harris, R. A., Kearney, M., Keddem, S., Calderbank, T., Tomczuk, L., Clapp, J. T., Perrone, J., Kranzler, H. R., Long, J. A., & Mandell, D. S. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00527-w · Cited by 3 · see citing works
Legal involvement and substance use treatment engagement and outcomes
Carter, A. C., & Dennis, C. B. (2021) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2021.1988492 · Cited by 3 · see citing works
The Broken Care Continuum for Young Adults With Opioid Addiction
Hadland, S. E. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.09.020 · Cited by 3 · see citing works
Gone Too Soon: Higher Pretreatment and Treatment Dropout Among Emerging Adults in a Women‐Specific Outpatient Treatment Service for Substance Use Disorders in Brazil
Borges, I. E. L., Stafuzza, G. D. R., Tótolo, P. L. F., Gomes, M. N. S., Cavalcante, E. J., Suen, P. J. C., dos Santos, A. A. M., Pan, P. M., Brasiliano, S., Hochgraf, P. B., et al. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70133 · Cited by 2 · see citing works
Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
Janzow, G. E., Harding, C., Flores, M. W., Borodovsky, J. T., Steinkamp, J., Marsch, L. A., & Schuman‐Olivier, Z. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100045 · Cited by 2 · see citing works
Self-citation

A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders
Dayal, P., & Balhara, Y. P. S. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.06.004 · Cited by 34 · see citing works
Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults
Peck, K. R., Ochalek, T. A., Badger, G. J., & Sigmon, S. C. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107879 · Cited by 9 · see citing works
Older Age Is Associated With Long‐Term Retention in Buprenorphine Treatment for Opioid Use Disorder
Groeger, J. L., Lu, T. Y., Jakubowski, A. U., Zhang, C., Deng, Y., Perez, H., DiRenno, F. A., Jadow, B. M., Hayes, B. T., Nahvi, S., et al. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70274 · Cited by 2 · see citing works
Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review
Dalton, K., Bishop, L., & Darcy, S. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107005 · Cited by 35 · see citing works
Matching treatment to develoment: emerging adults and substance-use disorder
Dalton, K. (2019) · Memorial University Research Repository (Memorial University)

Authors: Schuman-Olivier, Z., Weiss, R. D., Hoeppner, B. B., Borodovsky, J., & Albanese, M. J.
Affiliations: Harvard University (US)
Cambridge Health Alliance (US)
ORCID: Schuman-Olivier, Zev
Weiss, Roger D.
Hoeppner, Bettina B.
Borodovsky, Jacob
Venue: Journal of Substance Abuse Treatment
Publisher: Elsevier BV
Published: 2014-09
Volume: 47
Issue: 3
Pages: 202-212
ISSN: 0740-5472 (ISSN-L)
DOI: 10.1016/j.jsat.2014.04.006
PMC: PMC4180514
OpenAlex: W2164375280
Cited by: 127
References: 75
Citations by year: 2026: 10 · 2025: 8 · 2024: 13 · 2023: 3 · 2022: 15 · 2021: 17 · 2020: 22 · 2019: 11 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 3 · 2014: 1
FWCI: 7.96
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Substance Abuse Treatment (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Substance Abuse and Mental Health Services Administration
National Institute on Drug Abuse (K24DA022288, L30 DA027330, K01DA027097, U10DA015831, U10-DA15831)
National Center for Research Resources (UL1RR025758)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords: emerging adults, buprenorphine, treatment retention, opioid use disorder, addiction treatment, collaborative care, nursing care management, intensive outpatient treatment, relapse, treatment discontinuation, age differences
MeSH terms: Adolescent, Adult, Aging, Buprenorphine, Female, Humans, Male, Narcotic Antagonists, Opioid-Related Disorders, Patient Compliance, Patient Dropouts, Recurrence, Retrospective Studies, Substance Abuse Detection, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emerging adult age status predicts poor buprenorphine treatment retention

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks